ACRX Historical PE Ratio image   This ACRX PE ratio history page last updated 11/15/2022
ACRX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
2.43-0.94-3.76NA
Q2 2022
8/11/2022
6.20-1.20-4.80NA
Q1 2022
5/16/2022
4.20-1.20-4.80NA
Q4 2021
3/10/2022
8.60-1.20-4.80NA
Q3 2021
11/15/2021
15.00-1.40-5.60NA
Q2 2021
8/16/2021
22.40-1.60-6.40NA
Q1 2021
5/17/2021
23.60-1.60-6.40NA
Q4 2020
3/15/2021
43.60-2.00-8.00NA
Q3 2020
11/5/2020
37.40-2.00-8.00NA
Q2 2020
8/10/2020
27.60-1.60-6.40NA
Q1 2020
5/11/2020
33.80-4.00-16.00NA
Q4 2019
3/16/2020
16.80-3.60-14.40NA
Q3 2019
11/6/2019
38.20-3.20-12.80NA
Q2 2019
8/5/2019
48.20-3.20-12.80NA
Q1 2019
5/8/2019
70.20-3.40-13.60NA
Q4 2018
3/7/2019
75.20-3.60-14.40NA
Q3 2018
11/2/2018
96.00-4.20-16.80NA
Q2 2018
8/2/2018
52.00-4.00-16.00NA
Q1 2018
5/9/2018
50.00-4.60-18.40NA
Q4 2017
3/8/2018
38.00-4.00-16.00NA
Q3 2017
11/9/2017
39.00-5.60-22.40NA
Q2 2017
8/1/2017
68.00-5.80-23.20NA
Q1 2017
5/8/2017
57.00-6.80-27.20NA
Q4 2016
3/2/2017
64.00-4.20-16.80NA
Q3 2016
11/1/2016
56.00-5.00-20.00NA
Q2 2016
7/28/2016
61.60-4.80-19.20NA
Q1 2016
5/2/2016
65.00-5.00-20.00NA
Q4 2015
3/7/2016
80.00-4.80-19.20NA
Q3 2015
10/29/2015
67.002.208.807.6
Q2 2015
8/3/2015
81.00-4.00-16.00NA
Q1 2015
5/4/2015
84.00-5.40-21.60NA
Q4 2014
3/9/2015
110.20-6.40-25.60NA
Q3 2014
11/10/2014
120.60-2.60-10.40NA
Q2 2014
8/11/2014
129.00-6.00-24.00NA
Q1 2014
5/8/2014
198.40-4.40-17.60NA
Q4 2013
3/3/2014
224.80-3.60-14.40NA
Q3 2013
11/5/2013
138.60-5.20-20.80NA
Q2 2013
8/12/2013
216.40-4.40-17.60NA
Q1 2013
5/8/2013
118.00-6.80-27.20NA
Q4 2012
3/12/2013
99.80-8.20-32.80NA
Q3 2012
11/6/2012
58.00-7.60-30.40NA
ACRX PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
2.43-0.94-4.54NA
Q2 2022
8/11/2022
6.20-1.20-5.00NA
Q1 2022
5/16/2022
4.20-1.20-5.40NA
Q4 2021
3/10/2022
8.60-1.20-5.80NA
Q3 2021
11/15/2021
15.00-1.40-6.60NA
Q2 2021
8/16/2021
22.40-1.60-7.20NA
Q1 2021
5/17/2021
23.60-1.60-7.20NA
Q4 2020
3/15/2021
43.60-2.00-9.60NA
Q3 2020
11/5/2020
37.40-2.00-11.20NA
Q2 2020
8/10/2020
27.60-1.60-12.40NA
Q1 2020
5/11/2020
33.80-4.00-14.00NA
Q4 2019
3/16/2020
16.80-3.60-13.40NA
Q3 2019
11/6/2019
38.20-3.20-13.40NA
Q2 2019
8/5/2019
48.20-3.20-14.40NA
Q1 2019
5/8/2019
70.20-3.40-15.20NA
Q4 2018
3/7/2019
75.20-3.60-16.40NA
Q3 2018
11/2/2018
96.00-4.20-16.80NA
Q2 2018
8/2/2018
52.00-4.00-18.20NA
Q1 2018
5/9/2018
50.00-4.60-20.00NA
Q4 2017
3/8/2018
38.00-4.00-22.20NA
Q3 2017
11/9/2017
39.00-5.60-22.40NA
Q2 2017
8/1/2017
68.00-5.80-21.80NA
Q1 2017
5/8/2017
57.00-6.80-20.80NA
Q4 2016
3/2/2017
64.00-4.20-19.00NA
Q3 2016
11/1/2016
56.00-5.00-19.60NA
Q2 2016
7/28/2016
61.60-4.80-12.40NA
Q1 2016
5/2/2016
65.00-5.00-11.60NA
Q4 2015
3/7/2016
80.00-4.80-12.00NA
Q3 2015
10/29/2015
67.002.20-13.60NA
Q2 2015
8/3/2015
81.00-4.00-18.40NA
Q1 2015
5/4/2015
84.00-5.40-20.40NA
Q4 2014
3/9/2015
110.20-6.40-19.40NA
Q3 2014
11/10/2014
120.60-2.60-16.60NA
Q2 2014
8/11/2014
129.00-6.00-19.20NA
Q1 2014
5/8/2014
198.40-4.40-17.60NA
Q4 2013
3/3/2014
224.80-3.60-20.00NA
Q3 2013
11/5/2013
138.60-5.20-24.60NA
Q2 2013
8/12/2013
216.40-4.40-27.00NA
Q1 2013
5/8/2013
118.00-6.80NANA
Q4 2012
3/12/2013
99.80-8.20NANA
Q3 2012
11/6/2012
58.00-7.60NANA
Quotes delayed 20 minutes

Email EnvelopeFree ACRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ACXP PE Ratio History
ADGI PE Ratio History
ADIL PE Ratio History
ADMA PE Ratio History
ADMP PE Ratio History
ADMS PE Ratio History
ADPT PE Ratio History
ADTX PE Ratio History
ADUS PE Ratio History
ADVM PE Ratio History
How should the ACRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like AcelRx Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ACRX Historical PE Ratio page.

What is the average historical PE for ACRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ACRX historical PE ratio using the annualized quarterly earnings method works out to 7.6.

What is the average historical PE for ACRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ACRX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ACRX Historical PE Ratio information for AcelRx Pharmaceuticals' stock. The average ACRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 7.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ACRX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ACRX historical PE result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for ACRX had been 2.43, and the most recent quarterly earnings result, annualized, was 8.8. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ACRX PE on 11/14/2022 based on annualized quarterly EPS was 0.3. Based on ACRX's history, that recent PE is low relative to the historical average, with the recent PE 96.1% lower than the historical average PE across our data set for AcelRx Pharmaceuticals.

For self directed investors doing their due diligence on ACRX or any other given stock, valuation analysis for ACRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate AcelRx Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACRX. Thanks for visiting, and the next time you need to research ACRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding ACPW, Institutional Holders of CELG, IMMR Videos.

 

ACRX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.